Treatment as Prevention for Hepatitis C (TraP Hep C) – a nationwide elimination programme in Iceland using direct‐acting antiviral agents-Reference-Cited by-同舟云学术

Treatment as Prevention for Hepatitis C (TraP Hep C) – a nationwide elimination programme in Iceland using direct‐acting antiviral agents

Published:2018-03-07 Issue:5 Volume:283 Page:500-507
ISSN:0954-6820
Container-title:Journal of Internal Medicine
language:en
Short-container-title:J Intern Med

Author:

Olafsson S.¹²,Tyrfingsson T.³,Runarsdottir V.³,Bergmann O. M.¹,Hansdottir I.³⁴,Björnsson E. S.¹²,Johannsson B.⁵,Sigurdardottir B.⁵,Fridriksdottir R. H.¹,Löve A.²⁶,Hellard M.⁷⁸⁹,Löve T. J.²¹⁰,Gudnason T.¹¹,Heimisdottir M.²¹²,Gottfredsson M.²⁵¹⁰^ORCID

Affiliation:

1. Division of Gastroenterology and Hepatology Landspitali University HospitalReykjavik Iceland

2. Faculty of Medicine School of Health Sciences University of IcelandReykjavik Iceland

3. SAA – National Center of Addiction MedicineReykjavik Iceland

4. Faculty of Psychology School of Health Sciences University of IcelandReykjavik Iceland

5. Division of Infectious DiseasesLandspitali University HospitalReykjavik Iceland

6. Division of Virology Landspitali University Hospital Reykjavik Iceland

7. Centre for Population Health Burnet Institute MelbourneVIC Australia

8. Department of Epidemiology and Preventive Medicine Monash University ClaytonVIC Australia

9. Department of Infectious Diseases Alfred Hospital Melbourne VIC Australia

10. Department of Science Landspitali University HospitalReykjavik Iceland

11. Chief Epidemiologist Directorate of Health Landspitali University Hospital Reykjavik Iceland

12. Division of Finance Landspitali University Hospital Reykjavik Iceland

Publisher

Wiley

Subject

Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/joim.12740

Reference33 articles.

1. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015;Global Burden of Disease Study;Lancet,2016

2. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews

3. Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection

4. The present and future disease burden of hepatitis C virus infections with today's treatment paradigm - volume 3

5. Eradication of hepatitis C infection: The importance of targeting people who inject drugs

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Towards eliminating hepatitis C as a public health threat: different speeds, different needs;Eurosurveillance;2024-07-25

2. Prevalence of HCV infection in Europe in the DAA era: Review;Liver International;2024-05-28

3. Viral Hepatitis C: From Unraveling the Nature of Disease to Cure and Global Elimination;Digestive Diseases;2024-05-08

4. Incidence of cirrhosis in Iceland—impact of the TraP HepC nationwide HCV elimination program;Scandinavian Journal of Gastroenterology;2024-04-27

5. Hepatitis C screening in Lithuania: first-year results and scenarios for achieving WHO elimination targets;BMC Public Health;2024-04-15